Drug Eluting Stents: Technology & Market Forecast
Medtech Reports
February 1, 2005 20 Pages - SKU: MEDT1172228
|
|
Latest research findings indicate that drug eluting stents (DES) reduce the need for re-intervention after PTCA to a greater extent than bare metal stents (BMS).
The market for drug eluting stents has shown explosive growth since its inception and in 2004 it reached an estimated $4.2 billion in revenue worldwide.
Medtech Ventures' Drug Eluting Stents - Technology & Market Forecast report provide a brief, but thorough, analysis of this market with profiles of leading participants and forecasts to the year 2010.
Report Highlights:
- Current state of the science for coronary artery angioplasty and stenting.
- Current state of the technology for drug eluting stents
- Recent clinical trials and their findings.
- Current market for drug eluting stents.
- Potential market for Drug Eluting Stents.
- Leading players in the drug eluting stents market and potential new entrants.
- Market forecasts till 2010.
Drug Eluting Stents: Market & Technology Forecast report offers a short but thorough analysis of the potential for the global market for drug eluting stents. It is targeted at busy Medtech executives scanning for windows of opportunities opening in this space.
|
- 1. Executive Summary
- 2. State of the Science
- 2.1 Coronary Artery Disease (CAD)
- 2.1.1 Epidemiology
- 2.1.2 Diagnosis
- 2.1.3 Management
- 2.2 Medical Management
- 2.3 Coronary Artery Bypass & Graft (CABG)
- 2.4 Percutaneous Transluminal Coronary Angioplasty (PTCA)
- 2.5 Clinical Trials Update
- 3. State of the Technology
- 3.1 Procedure
- 3.2 Drug Eluting Stents Design & Technology
- 3.3 Leading Companies & Their Products
- 3.4.1 Abbott
- 3.4.2 Boston Scientific
- 3.4.3 Cook
- 3.4.4 Johnson & Johnson
- 3.4.4.1 Cordis
- 3.4.1.2 Guidant
- 3.4.5 Medtronic
- 3.4.6 Terumo
- 3.4. Other Companies in the Space
- 3.4.1 Advanced Bio Prosthetic Surfaces
- 3.4.2 Allvivo
- 3.4.3 Biocompatibles
- 3.4.4 Biointerface
- 3.4.5 Biosensors International
- 3.4.6 Biotronik
- 3.4.7 CardioTech
- 3.4.8 Conor Medsystems
- 3.4.9 Devax
- 3.4.10 Endovasc
- 3.4.11 Implant Sciences
- 3.4.12 Lombard Medical
- 3.4.13 Medical Ventures
- 3.4.14 Orbus Medical Technologies
- 3.4.15 Reva Medical
- 3.4.16 Sorin Biomedica
- 3.4.17 Translumina
- 4. Market Forecast
- 4.1 The Opportunity
- 4.2 Market Potential
- 4.3 Market Forecast
Share this report
Other tasks Related Markets Cardiovascular Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
